Hyperplasia: all 882 studies
Page 6 of 9. Open to participants first (96), then studies with results posted, then the rest; newest registration first within each.
- Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic HyperplasiaTerminatedNCT02918227Not applicable
- Irisin Hormone Levels in Endometrial HyperplasiaStatus unknownNCT02903797
- Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate CancersCompletedNCT02873117
- Apoptotic Signaling Pathways in Rats With Endometrial HyperplasiaCompletedNCT02872818Phase 4
- Castleman Disease Collaborative Network BiobankWithdrawnNCT02871050
- Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic HyperplasiaCompletedNCT02869971Phase 3
- Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck ContractureStatus unknownNCT02869061Phase 1/2
- The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile DysfunctionStatus unknownNCT02862483Phase 3
- A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPHCompletedNCT02855892Phase 2
- Unlock the Cell: Castleman's Disease Flow Cytometry StudyCompletedNCT02853968
- Information Improvement for Surgical Patients Through Portable Video MediaCompletedNCT02846467Not applicable
- A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male SubjectsCompletedNCT02839122Phase 1
- Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate HyperplasiaStatus unknownNCT02827578Phase 3
- Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the ProstateWithdrawnNCT02822963
- Prostate Artery Embolization for Symptomatic Benign Prostatic HyperplasiaCompletedNCT02822924Not applicable
- Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive PatientsStatus unknownNCT02793791Not applicable
- The Zenflow Spring System Feasibility and Safety StudyStatus unknownNCT02786290Not applicable
- Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic SyndromeCompletedNCT02778776Phase 3
- Sexual Steroids: Relationship Between Serum and Prostatic Tissue LevelCompletedNCT02778243Not applicable
- Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the ProstateStatus unknownNCT02749604Phase 4
- Superb Microvascular Imaging in Focal Nodular HyperplasiaCompletedNCT02737865Not applicable
- HoLEP (50W) vs. HoLEP (100W) for Treatment of BPHCompletedNCT02737241Not applicable
- PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male VolunteersCompletedNCT02715401Phase 1
- Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder SymptomsCompletedNCT02715024Phase 4
- Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male VolunteersCompletedNCT02712411Phase 1
- Video Colposcopy in Women With DysplasiaCompletedNCT02697175Not applicable
- Bipolar Versus Monopolar Resection of Benign Prostate HyperplasiaCompletedNCT02681471Not applicable
- Analysis of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia Using Embosphere MicrospheresWithdrawnNCT02679430Not applicable
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 CapsulesCompletedNCT02667938Phase 3
- Study to Compare the Safety and Pharmacokinetics of CKD-397CompletedNCT02645890Phase 1
- Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic HyperplasiaCompletedNCT02639442Not applicable
- Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)CompletedNCT02637960Phase 2/3
- "Parathyroid Tissues Anatomic Localizations Are Displaced Downward in Parathyroid Hyperplasia Cases"Status unknownNCT02636075
- EC905 Pharmacokinetic Profile StudyCompletedNCT02634489Phase 1
- Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and GastrinCompletedNCT02620696Phase 1
- Coldplay Cryoablation of Dysplastic Squamous Tissue in Patients With Esophageal Squamous Cell DysplasiaCompletedNCT02605759Not applicable
- Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic HyperplasiaStatus unknownNCT02592473Not applicable
- Assessment of Renal Artery Fibromuscular Dysplasia: From Diagnosis to TreatmentCompletedNCT02586870Not applicable
- Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male SubjectsCompletedNCT02578953Phase 1
- COrticosteroid in Congenital Adrenal HyperplasiaStatus unknownNCT02552251Phase 2/3
- Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.CompletedNCT02524236Early Phase 1
- Safety and Efficacy of OCL 503 in Prostate Artery EmbolizationCompletedNCT02509975Not applicable
- Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male SubjectsCompletedNCT02509104Phase 1
- Study Into Treatment of Hyperplasia of Mammary GlandsStatus unknownNCT02505256
- Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational PlanStatus unknownNCT02496442Not applicable
- Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly PatientsCompletedNCT02483819
- Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male VolunteersCompletedNCT02447367Phase 1
- Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm BabiesCompletedNCT02443961Phase 1
- Sequelae of Developmental Dysplasia of the HipActive, not recruitingNCT02431871
- Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem CellsCompletedNCT02425800
- A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle BiopsyCompletedNCT02423759Phase 4
- Comparison of Dilatation & Curettage and Endometrial Aspiration Biopsy Accuracy in Patients Treated With Progestin for Endometrial Hyperplasia: A Korean Gynecologic Oncology Group StudyStatus unknownNCT02412072
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPHCompletedNCT02390882Phase 3
- Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US StudyCompletedNCT02381366Phase 1/2
- TRT on BPH Hypoganadal MetS Patients. Florence-PROTESTCompletedNCT02366975Phase 4
- Safety and Pharmacokinetic Characteristics of DKF-313CompletedNCT02352311Phase 1
- Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal HyperplasiaWithdrawnNCT02349503Phase 1
- Does Benign Prostatic Obstruction Cause Hypertension?CompletedNCT02347436
- Ultrasound-Guided Photoselective Vaporization of the ProstateCompletedNCT02346500Early Phase 1
- Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical HyperplasiaCompletedNCT02342730Not applicable
- The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting HysterectomyStatus unknownNCT02335203Phase 2
- Effects of EPA on Prostate Cancer Cells Proliferation and Quality of LifeActive, not recruitingNCT02333435Phase 2
- HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPHCompletedNCT02332538Not applicable
- Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized TrialCompletedNCT02330471Phase 3
- A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaCompletedNCT02326454Phase 2
- Soft Tissue Pathology in Hip Dysplasia Before and After Periacetabular OsteotomyCompletedNCT02311166
- A Prospective Investigation Using the Expired Breath Ethanol TestCompletedNCT02304549
- Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTSCompletedNCT02303769Phase 3
- Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding TendencyStatus unknownNCT02293759Phase 4
- GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCTCompletedNCT02283684Phase 4
- Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.Status unknownNCT02279615Phase 4
- Digital Rectal Exam Proficiency ToolStatus unknownNCT02278679
- Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract SymptomsCompletedNCT02252367Phase 4
- Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric PatientsCompletedNCT02248467
- Observational Study of Tamsulosin in Patients With Benign Prostatic HyperplasiaCompletedNCT02245555
- The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)CompletedNCT02245542
- Safety Profile of Secotex ® in Patients With Benign Prostatic HyperplasiaCompletedNCT02245529
- Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)CompletedNCT02245503
- Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary SymptomsCompletedNCT02245490Phase 4
- Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)CompletedNCT02244346
- Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)CompletedNCT02244320
- Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic BlockadeCompletedNCT02244307
- FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)CompletedNCT02244294Phase 2
- Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244268
- FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244255Phase 4
- Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244242Phase 4
- Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) PatientsCompletedNCT02244229Phase 4
- Impact of Bladder Underactivity on Treatment Outcomes of Laser ProstatectomyStatus unknownNCT02243540
- Predictors of de Novo Urge Urinary Incontinence After Photoselective Vaporization of the ProstateStatus unknownNCT02243085
- Impact of Postoperative Pyuria on Treatment Outcomes After PVPStatus unknownNCT02241902
- Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and TamsulosinCompletedNCT02239484Phase 1
- Piecemeal Versus En Bloc Resection of Large Rectal AdenomasTerminatedNCT02238938Not applicable
- Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval DiseaseSuspendedNCT02223975
- Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic HyperplasiaCompletedNCT02206243
- Evaluation of T1rho Magnetic Resonance Imaging for Diagnosis of Cartilage Lesions in Hips With Developmental DysplasiaStatus unknownNCT02185365
- Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted StatesCompletedNCT02184585Phase 1
- Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and TamsulosinCompletedNCT02180997Phase 1
- A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional FormulationCompletedNCT02180789Phase 4
- Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)CompletedNCT02167919Not applicable
- Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 GramsStatus unknownNCT02167009Not applicable